Individuals Who are 60 Years or Older or Who Have Other High-Risk Factors for Adverse COVID-19 Outcomes to Receive VIP Access During First Hour of Each Day

Responding to the COVID-19 pandemic, Cigna today announced several actions to support and protect its colleagues in the United States so they can continue serving the company's more than 170 million customer relationship worldwide.

On March 5, U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subject to stringent personnel, quality control, and proficiency testing requirements.

New Integration with Microsoft Teams will Improve Care Team Collaboration for Healthcare Providers

In honor of International Rare Disease Day, a young rare disease advocate with a leukodystrophy, Ellie McGinn, presented her doctors at Kennedy Krieger Institute's Moser Center for Leukodystrophies with $450,000, bringing the total she and her family raised for research of the rare brain disease, Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL), to $1.6 million in four years.

Sanofi U.S. today announced that it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation relating to certain financial donations made in 2015 and 2016 to an independent charity patient assistance foundation that aided patients living with multiple sclerosis.

Updated results from CheckMate -214 study show that more than 50% of patients treated with Opdivo plus Yervoy were alive at 42 months compared to 39% of patients treated with sunitinib

The geko™ device now in routine use across multiple UK NHS hospitals and internationally.

Rare Disease Patients will receive Whole Genome Sequencing with Rare Disease Reports for $299 (€289). Patient Groups are encouraged to contact Dante Labs to develop personalized reports for their members (ex. Epilepsy Report for Epilepsy Groups).

Advanced Sterilization Products (ASP) released today an interview with experts Ryan Lewis, M.D., Senior Director of Medical Affairs and Medical Safety, and Jeremy Yarwood, Vice President of Research and Development.

In the ongoing war against Coronavirus, a new technology can provide much-needed protection and benefits for patients and healthcare workers.

Company also Receives a Notice of Allowance from the USPTO for a New AV-101 U.S. Patent for Treatment of Dyskinesia Induced by Levodopa Therapy

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, today announced additional patient data from its ongoing Phase I/IIa clinical study of OpRegen®, the Company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry age-related macular degeneration (dry AMD), a leading cause of adult blindness in the developed world with no FDA-approved treatment options.

Integrated care teams and care management tools led to 3,600 fewer bed days in a year

Merry & Bright - Brainwave Christmas Illuminations and Surprises Friends Visiting with Brainwave Illumination

Minimally Invasive Spiration® Valve System Now Recommended as Part of Standard of Care for Treatment of Severe Emphysema by International Clinical Guidelines

Add Teaser here

Novel Drug Delivery Technology Strengthens Targeted Oncologic Therapy Approach

Trial of Voclosporin Meets All Primary and Secondary Endpoints with Clean Safety Profile

Landmark study reports greater success with minimally invasive vascular access procedure